Search This Blog

Thursday, January 30, 2020

Biogen EPS beats by $0.28, beats on revenue

Biogen (NASDAQ:BIIB): Q4 Non-GAAP EPS of $8.34 beats by $0.28; GAAP EPS of $8.08 beats by $0.78.
Revenue of $3.67B (+4.0% Y/Y) beats by $140M.
Press Release
https://seekingalpha.com/news/3536212-biogen-eps-beats-0_28-beats-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)